Fakhrul Ahsan

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	7004	2705
h-endeksi	44	27
i10-endeksi	91	65

580

290

145

435

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202536 80 104 125 127 147 174 275 251 300 322 361 367 407 384 364 406 455 580 522 542 504 97

Genel erişim

Tümünü görüntüle

40 makale

7 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Nilesh GuptaChief Scientific Officerttuhsc.edu üzerinde doğrulanmış e-posta adresine sahip
Brijeshkumar Patel, PhDChief Research & Development officeradvancedbioderma.com üzerinde doğrulanmış e-posta adresine sahip
Vivek Gupta, Ph.D.Associate Professor, Pharmaceutical Sciences, St. John's University College of Pharmacystjohns.edu üzerinde doğrulanmış e-posta adresine sahip
Mohammad(Shahriar) AbsarUS Food and Drug Administrationfda.hhs.gov üzerinde doğrulanmış e-posta adresine sahip
Taslim A. Al-HilalAssociate Professor, Departments of Molecular Pharmaceutics and BME, The University of Utahpharm.utah.edu üzerinde doğrulanmış e-posta adresine sahip
Amit RawatMylanmylan.com üzerinde doğrulanmış e-posta adresine sahip
Elias MeezanProfessor Emeritus of Pharmacology and Toxicologyuab.edu üzerinde doğrulanmış e-posta adresine sahip
Young M KwonDepartment of Pharmaceutical Sciences, Nova Southeastern Universitynova.edu üzerinde doğrulanmış e-posta adresine sahip
Farzana AlamResearch Associate Professor; College of Pharmacy; University of Utahpharm.utah.edu üzerinde doğrulanmış e-posta adresine sahip
Louisa Hope-WeeksTexas Tech Universityttu.edu üzerinde doğrulanmış e-posta adresine sahip
ANA ISABEL TORRES SUAREZCatedrática de Farmacia y Tecnología Farmacéutica. Universidad Complutense de Madriducm.es üzerinde doğrulanmış e-posta adresine sahip
Ali KhademhosseiniTerasaki Institute, Amazon, UCLA, Harvard, MITterasaki.org üzerinde doğrulanmış e-posta adresine sahip
Reza MehvarProfessor and Chair, Department of Biomedical & Pharmaceutical Scienceschapman.edu üzerinde doğrulanmış e-posta adresine sahip
Ikramy A. KhalilProfessor, Department of Pharmaceutics , Faculty of Pharmacy, Assiut Universityaun.edu.eg üzerinde doğrulanmış e-posta adresine sahip
Hany M. ibrahimDep. of Pharmaceutics,Faculty of Pharmacy, Al Azhar University & Misr International University (MIU)azhar.edu.eg üzerinde doğrulanmış e-posta adresine sahip
In-San KimKorea Institute of Science and Technologykist.re.kr üzerinde doğrulanmış e-posta adresine sahip

Takip et

Fakhrul Ahsan

California Northstate University

cnsu.edu üzerinde doğrulanmış e-posta adresine sahip

Drug Inhalational drug delivery Pulmonary hypertension 3D Printing and microfluidics


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages F Ahsan, IP Rivas, MA Khan, AIT Suárez Journal of controlled release 79 (1-3), 29-40, 2002	738	2002
The vagina as a route for systemic drug delivery A Hussain, F Ahsan Journal of controlled release 103 (2), 301-313, 2005	532	2005
Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets H Kadry, S Wadnap, C Xu, F Ahsan European Journal of Pharmaceutical Sciences 135, 60-67, 2019	297	2019
Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine C Thomas, A Rawat, L Hope-Weeks, F Ahsan Molecular pharmaceutics 8 (2), 405-415, 2011	281	2011
Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin S Bai, C Thomas, F Ahsan Journal of pharmaceutical sciences 96 (8), 2090-2106, 2007	215	2007
Absorption enhancers in pulmonary protein delivery A Hussain, JJ Arnold, MA Khan, F Ahsan Journal of Controlled Release 94 (1), 15-24, 2004	207	2004
Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome B Patel, N Gupta, F Ahsan European Journal of Pharmaceutics and Biopharmaceutics 89, 163-174, 2015	168	2015
In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals K Nahar, N Gupta, R Gauvin, S Absar, B Patel, V Gupta, ... European journal of pharmaceutical sciences 49 (5), 805-818, 2013	168	2013
Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation A Rawat, QH Majumder, F Ahsan Journal of Controlled Release 128 (3), 224-232, 2008	167	2008
PEG–PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin B Patel, V Gupta, F Ahsan Journal of controlled release 162 (2), 310-320, 2012	156	2012
Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption H Kadry, TA Al-Hilal, A Keshavarz, F Alam, C Xu, A Joy, F Ahsan International journal of pharmaceutics 544 (1), 285-296, 2018	155	2018
Oral delivery of proteins: progress and prognostication RB Shah, F Ahsan, MA Khan Critical Reviews™ in Therapeutic Drug Carrier Systems 19 (2), 2002	154	2002
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension V Gupta, N Gupta, IH Shaik, R Mehvar, IF McMurtry, M Oka, ... Journal of controlled release 167 (2), 189-199, 2013	133	2013
Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin S Bai, F Ahsan Pharmaceutical research 26, 539-548, 2009	130	2009
Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin T Yang, A Hussain, S Bai, IA Khalil, H Harashima, F Ahsan Journal of controlled release 115 (3), 289-297, 2006	122	2006
Recent progress in dendrimer-based nanocarriers S Bai, C Thomas, A Rawat, F Ahsan Critical Reviews™ in Therapeutic Drug Carrier Systems 23 (6), 2006	113	2006
Evaluation of human nasal RPMI 2650 cells grown at an air–liquid interface as a model for nasal drug transport studies S Bai, T Yang, TJ Abbruscato, F Ahsan Journal of pharmaceutical sciences 97 (3), 1165-1178, 2008	108	2008
Cyclodextrins in Nasal Delivery of Low-Molecular-Weight Heparins: In Vivo and in Vitro Studies T Yang, A Hussain, J Paulson, TJ Abbruscato, F Ahsan Pharmaceutical research 21, 1127-1136, 2004	107	2004
Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses C Thomas, V Gupta, F Ahsan International journal of pharmaceutics 379 (1), 41-50, 2009	105	2009
Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats F Ahsan, J Arnold, E Meezan, DJ Pillion Pharmaceutical research 18, 1742-1746, 2001	104	2001

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar